Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Solvonis Therap (SVNS) Share Price

Price 0.235p on 30-04-2026 at 13:59:10
Change -0.005p -2.08%
Buy 0.24p
Sell 0.23p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 3,000.00 at 0.24p
Day's Volume: 31,599,392
Last Close: 0.24p
Open: 0.24p
ISIN: GB00BMD1Z199
Day's Range 0.23p - 0.25p
52wk Range: 0.127p - 0.395p
Market Capitalisation: £16.00m
VWAP: 0.231549p
Shares in Issue: 6.81b

Sector: Medicine and Biotech

Solvonis Therap (SVNS) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 3,000 0.24p Ordinary
 14:59:07 - 30-Apr-26
Sell* 170,000 0.2325p Ordinary
 14:22:55 - 30-Apr-26
Sell* 252,994 0.2325p Ordinary
 14:20:27 - 30-Apr-26
Buy* 5,000 0.24p Ordinary
 13:29:30 - 30-Apr-26
Sell* 2,500 0.2311p Ordinary
 13:25:07 - 30-Apr-26
Buy* 800 0.24p Ordinary
 13:16:28 - 30-Apr-26
Buy* 1,000 0.24p Ordinary
 13:14:42 - 30-Apr-26
Buy* 6,220 0.24p Ordinary
 12:56:23 - 30-Apr-26
Buy* 185,502 0.2395p Ordinary
 12:38:13 - 30-Apr-26
Sell* 1,000 0.2311p Ordinary
 12:28:45 - 30-Apr-26
See more Solvonis Therap trades

Solvonis Therap (SVNS) Share Price History

Time period:
to
Date Open High Low Close Volume
29th Apr 2026 (Wed) 0.275 0.275 0.24 0.24 56,188,696
28th Apr 2026 (Tue) 0.29 0.269 0.269 0.269 22,055,109
27th Apr 2026 (Mon) 0.285 0.295 0.27 0.29 30,133,774
24th Apr 2026 (Fri) 0.285 0.285 0.275 0.28 65,091,950
23rd Apr 2026 (Thu) 0.305 0.32 0.285 0.285 34,597,689
22nd Apr 2026 (Wed) 0.305 0.32 0.305 0.305 75,660,667
21st Apr 2026 (Tue) 0.30 0.31 0.295 0.31 18,970,941
20th Apr 2026 (Mon) 0.28 0.32 0.30 0.306 104,543,651
17th Apr 2026 (Fri) 0.25 0.28 0.265 0.28 54,316,420
16th Apr 2026 (Thu) 0.26 0.275 0.255 0.255 14,277,782
15th Apr 2026 (Wed) 0.26 0.26 0.26 0.26 19,034,575
14th Apr 2026 (Tue) 0.26 0.26 0.25 0.26 34,618,421
13th Apr 2026 (Mon) 0.264 0.27 0.25 0.25 24,134,217
10th Apr 2026 (Fri) 0.27 0.27 0.27 0.27 1,259,529
9th Apr 2026 (Thu) 0.27 0.27 0.27 0.27 25,554,471
8th Apr 2026 (Wed) 0.27 0.27 0.27 0.27 22,989,698
7th Apr 2026 (Tue) 0.265 0.27 0.27 0.27 68,996,156
6th Apr 2026 (Mon) 0.26 0.26 0.26 0.26 0
3rd Apr 2026 (Fri) 0.26 0.26 0.26 0.26 0
2nd Apr 2026 (Thu) 0.24 0.26 0.23 0.26 75,340,170
1st Apr 2026 (Wed) 0.245 0.245 0.235 0.24 18,253,404
31st Mar 2026 (Tue) 0.26 0.245 0.24 0.245 16,817,151
30th Mar 2026 (Mon) 0.25 0.25 0.24 0.25 11,457,805
See more Solvonis Therap price history

Solvonis Therap (SVNS) Regulatory News

Date Source Headline
29th Apr 2026 7:00 am RNS Final Results
22nd Apr 2026 7:00 am RNS-R Appointment of Water Tower Research
20th Apr 2026 8:32 am RNS-R US CNS Executive Order
8th Apr 2026 7:00 am RNS Granted U.S. Patent from PTSD Discovery Programme
31st Mar 2026 7:00 am RNS Granted U.S. Patent from PTSD Discovery Programme
10th Mar 2026 7:00 am RNS SVN-114 selected for PTSD discovery programme
28th Jan 2026 7:00 am RNS Expansion of SVN-015 into depression
7th Jan 2026 7:00 am RNS US Patent allowance for PTSD discovery programme
22nd Dec 2025 7:00 am RNS Research and Development Update - Q4 2025
22nd Dec 2025 7:00 am RNS Research and Development Update – Q4 2025
See more Solvonis Therap regulatory news

Solvonis Therap (SVNS) Share News

EARNINGS: Sanderson swings to profit; Keystone Law revenue climbs

29th Apr 2026 12:07

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Catenai renews contract; Angus sees production uplift

20th Apr 2026 19:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

WINNERS & LOSERS: Kosmos Energy climbs; Feedback hit by NHS delay

20th Apr 2026 11:20

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More

IN BRIEF: Solvonis Therapeutics hails US patent from PTSD programme

8th Apr 2026 14:31

Solvonis Therapeutics PLC - London-based biopharmaceutical company, focused on central nervous system disorders - Celebrates second US patent by United States Patent & Trademark Office, covering a further monoamine modulator compound series arising from its proprietary post-traumatic stress disorder discovery programme. The patent, U.S. Patent No. 12,595,269, was issued on Tuesday. On March 31, the company had announced the first such patent, U.S. Patent No. 12,590,077. Read More

EARNINGS AND TRADING: Ondine trial on track; Ensilica's contract wins

10th Mar 2026 16:34

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

See more Solvonis Therap news
FTSE 100 Latest
Value10,361.52
Change148.41

Login to your account

Forgot Password?

Not Registered